Yersinia enterocolitica is a major cause of enteritis in much of the industrialized world (5) . Enteritis due to this organism occurs primarily in infants and young children, and infections in the United States are reported to be more common in the North than in the South. Y. enterocolitica serogroup 0:3, the most common serogroup in Europe, Japan, and Canada, was relatively rare in the United States until the 1980s (1) . Recent reports indicate the emergence of serogroup 0:3 in New York City and New York State (2, 3, 13) and in California (1). Serogroup 0:3 surpassed serogroup 0:8 as the most common Y. enterocolitica serogroup sent to the Yersinia Reference Laboratory, Centers for Disease Control (CDC) (9) . Animals, especially swine, have been shown to serve as the reservoir for Y. enterocolitica serogroup 0:3 (14) . In the United States, consumption of contaminated food and milk products has been associated with outbreaks of other Y. enterocolitica (non-0:3) serogroups (9) . In most sporadic cases, the source of infection remains obscure.
( (9) . This precipitated our interest in another systematic survey for this pathogen in our patient population, which is urban, poor, and predominantly black.
All (7, 290) (15) . Isolates were also tested for calcium-dependent growth on Congo red-magnesium oxalate agar which correlates with the presence of a virulence plasmid (12) . Isolates from December 1989 and January 1990 were serogrouped with 0:3 antiserum provided by the CDC for a multicenter study (10) and then forwarded to the CDC for confirmation and further testing. Yersinia isolates from 1 February 1990 through 28 February 1991 were not serogrouped or tested for in vitro virulence markers. Y. enterocolitica was isolated from 76 patients, which constitutes an isolation rate of about 1.0% of the 7,290 rectal swab specimens submitted for culture (Table 1) . Salmonella, Shigella, and Campylobacter spp. were isolated more frequently than Y. enterocolitica. Most patients (74 of 76) from whom Y. enterocolitica was isolated were children. In children -12 months old, Y. enterocolitica was second in frequency only to Salmonella spp. (Table 1) . Of the 76 patients from whom Y. enterocolitica was isolated, 15 (19.8%) were hospitalized because of the severity of their disease. Of these 15, 2 had concurrent bacteremia and 14 were <12 months old.
Seasonal differences in Y. enterocolitica isolation rates were seen. The winter months (December, January, and February) had the highest number of cases. The other seasons were fairly comparable in the number of cases identified, which ranged from four to nine.
There were 37 Y. enterocolitica strains isolated between 1 December 1988 and 30 January 1990. These isolates were referred to the CDC for further testing. Of these 37, 33 (89%) were serogroup 0:3, 1 was 0:1,2,3, 1 was 0:5,2,7, and 2 did not react in sera to any pathogenic serogroups. The two isolates with nonpathogenic serogroups did not exhibit in vitro markers of virulence. The 35 virulent Y. enterocolitica isolates were all from children, and 28 of the 35 (80%) were from children who were 12 months old or less.
Cases of Y. enterocolitica occurred throughout the year in our patient population and increased in the winter months. This contrasts with data from Canada which indicated highest isolation rates in the summer (11) . The Y. enterocolitica isolates from the Canadian study were predominantly serogroup 0:3, as were ours.
Data from this Y. enterocolitica survey in Atlanta agreed closely with data from the state of New York (8) . Neither study showed a summer peak for Y. enterocolitica isolation; in both, the highest frequency for Y. enterocolitica was in children 1 year old or less.
The association between chitterling preparation during the Thanksgiving-Christmas holiday period and cases of Y. enterocolitica infection has been emphasized during the study period (9, 10) . Despite efforts to educate the public about the need for careful preparation of chitterlings (4), cases again increased during the Thanksgiving-Christmas holiday season in both 1990 and 1991. Further public health intervention, as well as further study of food sources and modes of transmission of Y. enterocolitica, may be necessary.
A prior study concluded that routine screening for Y. enterocolitica on CIN agar was not a cost-effective procedure in that patient population (6) . By contrast, our data suggest that routine screening for Y. enterocolitica is warranted at certain hospitals, especially of children s1 year of age. We suggest that institutions with large pediatric populations, regardless of their geographic locations, assess the need for routine screening for Y. enterocolitica.
